We are thrilled to announce our participation at the European Stroke Organisation Conference (ESOC) from 21ˢᵗ to 23ʳᵈ May 2025 in Helsinki, Finland.

Last weekend, Moleac hosted a Scientific Conference in Bali in collaboration with our Indonesian partner, Ferron PT Pharmaceuticals.

Last weekend, Moleac held the Scientific Conference in Kotor, Montenegro, focusing on the integration of natural therapies in neurological care, covering key insights into stroke and Alzheimer’s disease.

This week is Earth Day! Moleac is proud to support Seacology (www.seacology.org) in their efforts to protect our planet and empower communities.

📰🧠🔬 POST-STROKE STUDY HIGHLIGHTS – Post-stroke cognitive impairment and dementia research in Southeast Asia (SEA): A scoping review by Mtambo, M. L., Ragunathan, T., Mohan, D., Warren, N., Su, T. T., & Quek, K. F.

Last week in Vienna, alongside the Alzheimer’s and Parkinson’s Diseases (AD/PD) 2025 Conference, we had the pleasure of hosting our symposium “Expanding Horizons for Alzheimer’s Disease Management.”

Moleac is proud to partner with Kythe Foundation Inc., www.kythe.org, a remarkable organization in the Philippines that supports over 18,000 hospitalized children battling cancer and chronic illnesses.

Our team is at the AD/PD International Conference in Vienna!

📰🧠🔬 TRAUMATIC BRAIN INJURY (TBI) STUDY HIGHLIGHTS – Longitudinal healthcare use after pediatric brain injury: A population-based birth cohort study by Chan V, Wirianto CS, Balogh R, Escobar MD.